Sanatorio Otamendi Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00552669
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Departamento de Cardiologia Intervencionista, Sanatorio Otamendi | Sanatorio Otamendi y Miroli

Active Ingredients

Drugs in Phase 4 Trials (1)

sirolimus (rapamune) (1 trial)

Drugs in Phase 3 Trials (2)

hydroxyethyl starch (voluven) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronary Restenosis (Phase 4)

Heart Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3